| Literature DB >> 33540568 |
Isabel M Guijarro1, Moisés Garcés1, Pol Andrés-Benito2, Belén Marín1, Alicia Otero1, Tomás Barrio1, Margarita Carmona2, Isidro Ferrer2, Juan J Badiola1, Marta Monzón1.
Abstract
The actual role of prion protein-induced glial activation and subsequent cytokine secretion during prion diseases is still incompletely understood. The overall aim of this study is to assess the effect of an anti-inflammatory treatment with dexamethasone on different cytokines released by neuroglial cells that are potentially related to neuroinflammation in natural scrapie. This study emphasizes the complex interactions existent among several pleiotropic neuromodulator peptides and provides a global approach to clarify neuroinflammatory processes in prion diseases. Additionally, an impairment of communication between microglial and astroglial populations mediated by cytokines, mainly IL-1, is suggested. The main novelty of this study is that it is the first one assessing in situ neuroinflammatory activity in relation to chronic anti-inflammatory therapy, gaining relevance because it is based on a natural model. The cytokine profile data would suggest the activation of some neurotoxicity-associated route. Consequently, targeting such a pathway might be a new approach to modify the damaging effects of neuroinflammation.Entities:
Keywords: cytokines; dexamethasone; neuroinflammation; prion diseases; scrapie
Year: 2021 PMID: 33540568 PMCID: PMC7912810 DOI: 10.3390/biom11020204
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X